Ten-year results confirm the finding that 6 months of neoadjuvant androgen-deprivation therapy (ADT) plus radiotherapy halves the risk of dying from prostate cancer, compared with radiotherapy alone. Medscape Medical News
Does the anti-inflammatory action of aspirin and other NSAIDs provide chemopreventive activity against prostate cancer? American Journal of Epidemiology
Gregory A. Daniels from UCSD describes how to integrate IL-2 into treatment for melanoma. Today is a dynamic time in melanoma therapy. University of California, San Diego, School of Medicine
Minimally invasive surgery for breast cancer is becoming popular, but the oncologic safety of these new procedures is often not being evaluated thoroughly. Medscape Medical News
Drs. John Leonard and Bruce Cheson review the major studies presented in large cell lymphoma and follicular lymphoma at ASH 2010. Medscape Hematology-Oncology